EBOS Group Limited/Announcement
EBOS Group Limited logo

Sybos notice regarding sale of shares in EBOS

Substantial Holder Notice18 November 2019EBOHealthcare

S Y B O S H O L D I N G S P T E L T D

360 ORCHARD ROAD #10-02, INTERNATIONAL BUILDING,

SINGAPORE 238869

3930905 v2


NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES


19 November 2019


NZX / ASX: EBO


NZX Limited ASX Limited

Level 1, NZX Centre 20 Bridge Street

11 Cable Street Sydney NSW

Wellington


Copy to: EBOS Group Limited


Sale of shares in EBOS Group Limited (ASX: EBO)

1. Sybos Holdings Pte Ltd (Sybos) has entered into an underwriting agreement with a financial

institution to sell 15,000,000 of its shares in EBOS Group Limited (ARBN 166 840 973)

(EBOS) (being approximately 9.3% of EBOS’s share capital) to investors invited to

participate in the bookbuild (Sale).

2. Sybos confirms that it does not possess any information that is not generally available and

that a reasonable person would expect to have a material effect on the price or value of

EBOS’s shares. The sale is being conducted by a fixed price bookbuild, which is expected

to be completed on 19 November 2019.

3. As a consequence of the Sale, Sybos is expected to substantially reduce its shareholding in

EBOS and the shares that are sold are expected to be widely held by investors allocated

shares in the Sale.

4. Sybos obtained its interest in EBOS in 2013 following EBOS's acquisition of the

pharmaceutical wholesaler Symbion. The sale follows a decision by the ultimate

shareholders of Sybos to diversify their assets.

Yours faithfully

Marshall H Byres

Director

Sybos Holdings Pte Limited



Important notice

Neither EBOS nor Sybos believe that Sybos is a controller of EBOS for the purposes of the Corporations Act 2001 (Cth)

(Corporations Act) (or for that matter under the Financial Markets Conduct Regulations 2014 and the Financial Markets

Conduct Act 2013). However, in case that assessment is incorrect, Sybos confirms the following information that would be

required were this a formal cleansing notice under the Corporations Act:

(a) Sybos will sell the relevant shares without disclosure under Part 6D.2 of the Corporations Act;

(b) this notice is being given under section 708A(5)(e) of the Corporations Act as modified by ASIC Corporations (Sale

Offers By Controllers) Instrument 2016/81; and

(c) as far as Sybos is aware, as at the date of this notice, EBOS has complied with:

(i) the provisions of Chapter 2M of the Corporations Act as they apply to EBOS; and

(ii) section 674 of the Corporations Act as it applies to EBOS.

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.